Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03221036
What this trial is testing

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Takeda 392
Large-scale testing (Phase 3)Looking for participantsNCT07577856
What this trial is testing

JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 644
Testing effectiveness (Phase 2)Study completedNCT00063830
What this trial is testing

ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07335055
What this trial is testing

HSK47388 in Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Haisco Pharmaceutical Group Co., Ltd. 150
Not applicableStudy completedNCT06998693
What this trial is testing

A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative Colitis

Who this might be right for
Ul
Xijing Hospital of Digestive Diseases 180
Large-scale testing (Phase 3)Study completedNCT00679380
What this trial is testing

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 514
Large-scale testing (Phase 3)Study completedNCT02100696
What this trial is testing

The Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 609
Not applicableActive Not RecruitingNCT05494606
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

Who this might be right for
Ulcerative Colitis
AbbVie 785
Early research (Phase 1)Study completedNCT03849599
What this trial is testing

Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Provention Bio, Inc. 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06867042
What this trial is testing

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

Who this might be right for
Ulcerative Colitis (UC)Ulcerative Colitis, Active Moderate
Jina Pharmaceuticals Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06619990
What this trial is testing

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Xencor, Inc. 270
Testing effectiveness (Phase 2)Looking for participantsNCT06850727
What this trial is testing

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)UC - Ulcerative Colitis
Odyssey Therapeutics 57
Testing effectiveness (Phase 2)Study completedNCT03178669
What this trial is testing

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
InDex Pharmaceuticals 213
Testing effectiveness (Phase 2)Looking for participantsNCT07012395
What this trial is testing

Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesColitis+1 more
Spyre Therapeutics, Inc. 645
Large-scale testing (Phase 3)Study completedNCT01320436
What this trial is testing

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sheba Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00718094
What this trial is testing

Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis

Who this might be right for
Mild to Moderately Active Ulcerative Colitis
University of Louisville 20
Testing effectiveness (Phase 2)Ended earlyNCT03298022
What this trial is testing

Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC

Who this might be right for
Ulcerative Colitis
AltruBio Inc. 24
Large-scale testing (Phase 3)Study completedNCT00577473
What this trial is testing

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

Who this might be right for
Ulcerative Colitis
Warner Chilcott 301
Testing effectiveness (Phase 2)Ended earlyNCT05672199
What this trial is testing

Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05782907
What this trial is testing

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
AbbVie 122
Next Page